Wells Fargo & Company Royalty Pharma PLC Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Royalty Pharma PLC stock. As of the latest transaction made, Wells Fargo & Company holds 70,120 shares of RPRX stock, worth $2.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,120

Previous 54,330 29.06%

Holding current value

$2.32 Million

Previous $1.54 Million 16.41%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$24.28 - $28.39 $383,381 - $448,278	15,790 Added 29.06%	70,120 $1.79 Million
Q3 2024 Nov 13, 2024	BUY	$25.63 - $29.27 $158,239 - $180,712	6,174 Added 12.82%	54,330 $1.54 Million
Q2 2024 Aug 13, 2024	SELL	$26.26 - $29.9 $57,483 - $65,451	-2,189 Reduced 4.35%	48,156 $1.27 Million
Q1 2024 May 10, 2024	BUY	$27.46 - $31.33 $973,539 - $1.11 Million	35,453 Added 238.07%	50,345 $1.53 Million
Q4 2023 Feb 09, 2024	BUY	$26.21 - $29.22 $8,151 - $9,087	311 Added 2.13%	14,892 $418,000
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $756,813 - $904,371	-28,820 Reduced 66.4%	14,581 $395,000
Q2 2023 Aug 15, 2023	BUY	$29.6 - $36.56 $242,779 - $299,865	8,202 Added 23.3%	43,401 $1.33 Million
Q1 2023 May 12, 2023	BUY	$32.77 - $39.4 $411,951 - $495,297	12,571 Added 55.56%	35,199 $1.27 Million
Q4 2022 Feb 13, 2023	SELL	$39.17 - $44.04 $633,378 - $712,126	-16,170 Reduced 41.68%	22,628 $894,000
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $145,242 - $162,615	3,642 Added 10.36%	38,798 $1.56 Million
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $283,238 - $333,728	7,547 Added 27.34%	35,156 $1.48 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $132,720 - $150,364	3,543 Added 14.72%	27,609 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $1.16 Million - $1.4 Million	-32,848 Reduced 57.72%	24,066 $959,000
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $1.78 Million - $2.08 Million	-49,210 Reduced 46.37%	56,914 $2.06 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $2.8 Million - $3.28 Million	70,277 Added 196.05%	106,124 $4.35 Million
Q1 2021 May 13, 2021	SELL	$42.34 - $52.82 $14.9 Million - $18.5 Million	-350,796 Reduced 90.73%	35,847 $1.56 Million
Q4 2020 Feb 09, 2021	BUY	$36.12 - $50.05 $12.9 Million - $17.9 Million	357,244 Added 1215.16%	386,643 $19.4 Million
Q3 2020 Nov 05, 2020	SELL	$38.56 - $48.36 $13 Million - $16.3 Million	-336,931 Reduced 91.97%	29,399 $1.24 Million
Q2 2020 Aug 13, 2020	BUY	$44.5 - $52.11 $16.3 Million - $19.1 Million	366,330 New	366,330 $17.8 Million

Others Institutions Holding RPRX

# of Institutions

433

Shares Held

294M

Call Options Held

508K

Put Options Held

118K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.4B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Royalty Pharma PLC Transaction History